PLA2G7 and acute coronary syndrome: ■Substituted pyrimidone;■Investigational for acute coronary syndrome (phase 3), atherosclerosis (phase 3), and diabetic retinopathy (phase 2);■Lipoprotein-associated phospholipase-A2 (Lp-PLA2) inhibitor.